Dermira (NASDAQ: DERM) reported Q3 EPS of ($0.23), $0.11 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $18.99 million.

For earnings history and earnings-related data on Dermira (DERM) click here.